MYD88 and cancer: Bohnert et al. demonstrated that the Lewis lung carcinoma (LLC) model of cancer cachexia resulted in an upregulation of Toll-like receptors (TLRs) and myeloid differentiation primary response gene 88 (MyD88) expression in skeletal muscle [123,124,125].